Hypoxic antiblastic stop-flow perfusion: Clinical outcome and pharmacokinetic findings

Journal of Chemotherapy

Volumn 16, Issue SUPPL. 5, 2004, Pages 44-47

  Pilati, Pierluigi ^a   Miotto, D ^a   Bertolo, S ^a   Minante, M ^a   Darisi, T ^a   Mocellin, S ^a   Casara, D ^a   Ori, C ^a   Foletto, M ^a   Rossi, C R ^a   Lise, M ^a   Nitti, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Solid tumors; Stop flow perfusion

Indexed keywords

DOXORUBICIN; MELPHALAN; MITOMYCIN C;

ADULT; AGED; BONE MARROW SUPPRESSION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONFERENCE PAPER; DRUG INFUSION; FEMALE; HUMAN; HYPOXIC ANTIBLASTIC STOP FLOW PERFUSION; INTERVENTIONAL RADIOLOGY; MALE; MELANOMA; SOFT TISSUE SARCOMA; SOLID TUMOR; TECHNIQUE; TOXICITY; TREATMENT OUTCOME;

EID: 20244373290     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009x.2004.11782383     Document Type: Conference Paper

References (10)

1. Heinemann V. Gemcitabine: progress in the treatment of pancreatic cancer. Oncology 2001;60:8-18.
2. Kerr DJ, Los G. Pharmacokinetic principles of locoregional chemotherapy. Cancer Surv 1993;17:105-22.
3. Aigner KR. Intra-arterial infusion: overview and novel approaches. Semin Surg Oncol 1998;14:248-53.
4. Pilati P, Mocellin S, Miotto D, et al. Stop-flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience. Eur J Surg Oncol 2002;28:544.
5. Skarsgard LD, Skwarchuk MW, Vinczan A, Kristl J, Chaplin DJ. The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake. Anticancer Res 1995;15:219-23.
6. Guadagni S, Fiorentini G, Palumbo G, et al. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer. Arch Surg 2001;136:105-12.
7. Rossi CR, Foletto M, Di Filippo F, et al. Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion. Cancer 1999;86:1742-9.
8. Rossi CR, Foletto M, Pilati P, Mocellin S, Lise M. Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 2002;29:400-9.
9. Tannock I. Cell kinetics and chemotherapy: a critical review. Cancer Treat Rep 1978;62:1117-33.
10. Guadagni S, Russo F, Rossi CR, et al. Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma. Am J Surg 2002;183:28-36.